531 related articles for article (PubMed ID: 9589844)
1. A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.
Walti H; Monset-Couchard M
Drug Saf; 1998 May; 18(5):321-37. PubMed ID: 9589844
[TBL] [Abstract][Full Text] [Related]
2. Natural vs synthetic surfactants in neonatal respiratory distress syndrome.
Halliday HL
Drugs; 1996 Feb; 51(2):226-37. PubMed ID: 8808165
[TBL] [Abstract][Full Text] [Related]
3. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
Dechant KL; Faulds D
Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
[TBL] [Abstract][Full Text] [Related]
4. Calfactant: a review of its use in neonatal respiratory distress syndrome.
Onrust SV; Dooley M; Goa KL
Paediatr Drugs; 1999; 1(3):219-43. PubMed ID: 10937453
[TBL] [Abstract][Full Text] [Related]
5. Exogenous surfactant use in neonates.
Ishisaka DY
Ann Pharmacother; 1996 Apr; 30(4):389-98. PubMed ID: 8729894
[TBL] [Abstract][Full Text] [Related]
6. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
Wiseman LR; Bryson HM
Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
[TBL] [Abstract][Full Text] [Related]
7. Lung surfactants.
Ghodrat M
Am J Health Syst Pharm; 2006 Aug; 63(16):1504-21. PubMed ID: 16896079
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
[TBL] [Abstract][Full Text] [Related]
9. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
Pfister RH; Soll R; Wiswell TE
Cochrane Database Syst Rev; 2009 Oct; (4):CD006180. PubMed ID: 19821357
[TBL] [Abstract][Full Text] [Related]
10. Recent clinical trials of surfactant treatment for neonates.
Halliday HL
Biol Neonate; 2006; 89(4):323-9. PubMed ID: 16770072
[TBL] [Abstract][Full Text] [Related]
11. Controversies: synthetic or natural surfactant. The case for natural surfactant.
Halliday HL
J Perinat Med; 1996; 24(5):417-26. PubMed ID: 8950721
[TBL] [Abstract][Full Text] [Related]
12. Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review.
Ainsworth SB; Milligan DW
Am J Respir Med; 2002; 1(6):417-33. PubMed ID: 14720029
[TBL] [Abstract][Full Text] [Related]
13. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
[TBL] [Abstract][Full Text] [Related]
14. Colfosceril palmitate. A pharmacoeconomic evaluation of a synthetic surfactant preparation (Exosurf Neonatal) in infants with respiratory distress syndrome.
Bryson HM; Whittington R
Pharmacoeconomics; 1994 Dec; 6(6):563-77. PubMed ID: 10155285
[TBL] [Abstract][Full Text] [Related]
15. The fate of exogenous surfactant in neonates with respiratory distress syndrome.
Hallman M; Merritt TA; Bry K
Clin Pharmacokinet; 1994 Mar; 26(3):215-32. PubMed ID: 8194284
[TBL] [Abstract][Full Text] [Related]
16. Natural surfactant for neonatal respiratory distress syndrome in very premature infants: a 1992 update.
Gortner L
J Perinat Med; 1992; 20(6):409-19. PubMed ID: 1293266
[TBL] [Abstract][Full Text] [Related]
17. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
Robertson B
Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
[TBL] [Abstract][Full Text] [Related]
18. Surfactant replacement therapy for pulmonary diseases.
Pramanik AK; Holtzman RB; Merritt TA
Pediatr Clin North Am; 1993 Oct; 40(5):913-36. PubMed ID: 8414715
[TBL] [Abstract][Full Text] [Related]
19. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
20. Surfactants: past, present and future.
Halliday HL
J Perinatol; 2008 May; 28 Suppl 1(Suppl 1):S47-56. PubMed ID: 18446178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
